Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000849636-17-000001
Filing Date
2017-01-13
Accepted
2017-01-13 14:09:04
Documents
1
Effectiveness Date
2017-01-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10877
  Complete submission text file 0000849636-17-000001.txt   12116
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

EIN.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-278400 | Film No.: 17527372
SIC: 2834 Pharmaceutical Preparations